These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9164776)

  • 21. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.
    Rock MJ; Mischler EH; Farrell PM; Wei LJ; Bruns WT; Hassemer DJ; Laessig RH
    Pediatrics; 1990 Jun; 85(6):1001-7. PubMed ID: 2187173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in Sweden.
    Schaedel C; Hjelte L; de Monestrol I; Johannesson M; Kollberg H; Kornfält R; Holmberg L
    Clin Genet; 1999 Oct; 56(4):318-22. PubMed ID: 10636451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis.
    Sarles J; Berthézène P; Le Louarn C; Somma C; Perini JM; Catheline M; Mirallié S; Luzet K; Roussey M; Farriaux JP; Berthelot J; Dagorn JC
    J Pediatr; 2005 Sep; 147(3):302-5. PubMed ID: 16182665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn screening for cystic fibrosis in Switzerland--consequences after analysis of a 4 months pilot study.
    Torresani T; Fingerhut R; Rueegg CS; Gallati S; Kuehni CE; Baumgartner MR; Barben J;
    J Cyst Fibros; 2013 Dec; 12(6):667-74. PubMed ID: 23712087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of specificity and sensitivity of IRT/IRT protocol in the cystic fibrosis newborn screening program: 6-year experience of three tertiary centers.
    Ramasli Gursoy T; Asfuroglu P; Sismanlar Eyuboglu T; Aslan AT; Yilmaz AI; Unal G; Kibar BS; Pekcan S; Hangul M; Kose M; Budakoglu II; Acican D
    Eur J Pediatr; 2023 Mar; 182(3):1067-1076. PubMed ID: 36565324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling.
    Mischler EH; Wilfond BS; Fost N; Laxova A; Reiser C; Sauer CM; Makholm LM; Shen G; Feenan L; McCarthy C; Farrell PM
    Pediatrics; 1998 Jul; 102(1 Pt 1):44-52. PubMed ID: 9651412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of newborn screening for cystic fibrosis in Norway. Results from the first three years.
    Lundman E; Gaup HJ; Bakkeheim E; Olafsdottir EJ; Rootwelt T; Storrøsten OT; Pettersen RD
    J Cyst Fibros; 2016 May; 15(3):318-24. PubMed ID: 26795017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Final results of the southwest German pilot study on cystic fibrosis newborn screening - Evaluation of an IRT/PAP protocol with IRT-dependent safety net.
    Sommerburg O; Stahl M; Hämmerling S; Gramer G; Muckenthaler MU; Okun J; Kohlmüller D; Happich M; Kulozik AE; Mall MA; Hoffmann GF
    J Cyst Fibros; 2022 May; 21(3):422-433. PubMed ID: 34764021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystic fibrosis newborn screening: the importance of bloodspot sample quality.
    Doull I; Course CW; Hanks RE; Southern KW; Forton JT; Thia LP; Moat SJ
    Arch Dis Child; 2021 Mar; 106(3):253-257. PubMed ID: 32859613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of 47,213 infants in neonatal screening for cystic fibrosis, using pancreatitis-associated protein and immunoreactive trypsinogen assays].
    Barthellemy S; Maurin N; Roussey M; Férec C; Murolo S; Berthézène P; Iovanna JL; Dagorn JC; Sarles J
    Arch Pediatr; 2001 Mar; 8(3):275-81. PubMed ID: 11270251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.
    Kay DM; Langfelder-Schwind E; DeCelie-Germana J; Sharp JK; Maloney B; Tavakoli NP; Saavedra-Matiz CA; Krein LM; Caggana M; Kier C;
    Pediatr Pulmonol; 2015 Aug; 50(8):771-80. PubMed ID: 26098992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newborn Screening for Cystic Fibrosis in California.
    Kharrazi M; Yang J; Bishop T; Lessing S; Young S; Graham S; Pearl M; Chow H; Ho T; Currier R; Gaffney L; Feuchtbaum L;
    Pediatrics; 2015 Dec; 136(6):1062-72. PubMed ID: 26574590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and clinical features of false-negative infants in a neonatal screening programme for cystic fibrosis.
    Padoan R; Genoni S; Moretti E; Seia M; Giunta A; Corbetta C
    Acta Paediatr; 2002; 91(1):82-7. PubMed ID: 11883825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sweat chloride and immunoreactive trypsinogen in infants carrying two
    Castellani C; Tridello G; Tamanini A; Assael BM
    Arch Dis Child; 2017 Jul; 102(7):644-646. PubMed ID: 26755536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study.
    Vernooij-van Langen AM; Loeber JG; Elvers B; Triepels RH; Gille JJ; Van der Ploeg CP; Reijntjens S; Dompeling E; Dankert-Roelse JE;
    Thorax; 2012 Apr; 67(4):289-95. PubMed ID: 22271776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the improvements in the newborn screening strategy for cystic fibrosis in the Balearic Islands.
    Bauça JM; Morell-Garcia D; Vila M; Pérez G; Heine-Suñer D; Figuerola J
    Clin Biochem; 2015 Apr; 48(6):419-24. PubMed ID: 25680858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False negatives in the newborn screening for cystic fibrosis in Western Andalusia: Results from a 10-year experience.
    Escudero-Ávila R; Delgado-Pecellín C; Moreno-Valera MJ; Carrasco-Hernández L; Quintana-Gallego ME; Delgado-Pecellín I
    Pediatr Pulmonol; 2023 Sep; 58(9):2464-2468. PubMed ID: 36196044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
    Padoan R; Bassotti A; Seia M; Corbetta C
    Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.